XML 28 R19.htm IDEA: XBRL DOCUMENT v3.23.1
Segment Reporting
3 Months Ended
Mar. 31, 2023
Segment Reporting [Abstract]  
Segment Reporting

13.  Segment Reporting

We report segment information based on the various industries in which our businesses operate and how we manage those businesses in accordance with our investment strategies, which may include: identifying and acquiring undervalued assets and businesses, often through the purchase of distressed securities; increasing value through management, financial or other operational changes; and managing complex legal, regulatory or financial issues, which may include bankruptcy or insolvency, environmental, zoning, permitting and licensing issues. Therefore, although many of our businesses are operated under separate local management, certain of our businesses are grouped together when they operate within a similar industry, comprising similarities in products, customers, production processes and regulatory environments, and when such businesses, when considered together, may be managed in accordance with one or more investment strategies specific to those businesses. Among other measures, we assess and measure segment operating results based on net income from continuing operations attributable to Icahn Enterprises. Certain terms of financings for certain of our businesses impose restrictions on the business’ ability to transfer funds to us, including restrictions on dividends, distributions, loans and other transactions.

Condensed Statements of Operations

Three Months Ended March 31, 2023

    

Investment

    

Energy

    

Automotive

    

Food Packaging

    

Real Estate

    

Home Fashion

    

Pharma

    

Holding Company

    

Consolidated

(in millions)

Revenues:

Net sales

$

$

2,286

$

287

$

118

$

7

$

40

$

20

$

$

2,758

Other revenues from operations

 

 

 

170

 

 

16

 

 

1

 

 

187

Net loss from investment activities

 

(443)

 

 

 

 

 

 

 

 

(443)

Interest and dividend income

 

144

 

5

 

 

 

 

 

 

22

 

171

Other (loss) income, net

 

(28)

 

3

 

 

(7)

 

 

 

 

 

(32)

 

(327)

 

2,294

 

457

 

111

 

23

 

40

 

21

 

22

 

2,641

Expenses:

Cost of goods sold

 

 

1,926

 

193

 

91

 

6

 

32

 

12

 

 

2,260

Other expenses from operations

 

 

 

145

 

 

13

 

 

 

 

158

Selling, general and administrative

 

3

 

46

 

132

 

14

 

4

 

10

 

13

 

7

 

229

Loss on deconsolidation of subsidiary

226

226

Interest expense

 

45

 

23

 

 

3

 

 

 

 

71

 

142

 

48

 

1,995

 

470

 

108

 

23

 

42

 

25

 

304

 

3,015

(Loss) before income tax benefit (expense)

 

(375)

 

299

 

(13)

 

3

 

 

(2)

 

(4)

 

(282)

 

(374)

Income tax (expense) benefit

 

 

(52)

 

 

4

 

 

 

 

64

 

16

Net (loss) income

 

(375)

 

247

 

(13)

 

7

 

 

(2)

 

(4)

 

(218)

 

(358)

Less: net (loss) income attributable to non-controlling interests

 

(204)

 

115

 

 

1

 

 

 

 

 

(88)

Net (loss) income attributable to Icahn Enterprises

$

(171)

$

132

$

(13)

$

6

$

$

(2)

$

(4)

$

(218)

$

(270)

Supplemental information:

Capital expenditures

$

$

44

$

10

$

2

$

2

$

$

$

$

58

Depreciation and amortization

$

$

84

$

19

$

7

$

3

$

2

$

7

$

$

122

Three Months Ended March 31, 2022

    

Investment

    

Energy

    

Automotive

    

Food Packaging

    

Real Estate

    

Home Fashion

    

Pharma

    

Holding Company

 

Consolidated

(in millions)

 

Revenues:

    

  

  

  

  

  

  

  

  

 

  

Net sales

$

$

2,373

$

407

$

101

$

17

$

55

$

15

$

$

2,968

Other revenues from operations

 

 

 

156

 

 

11

 

 

1

 

 

168

Net gain from investment activities

 

908

 

 

 

 

 

 

 

31

 

939

Interest and dividend income

 

40

 

 

 

 

 

 

 

2

 

42

Other (loss) income, net

 

(17)

 

(10)

 

2

 

1

 

 

 

1

 

(1)

 

(24)

 

931

 

2,363

 

565

 

102

 

28

 

55

 

17

 

32

 

4,093

Expenses:

 

Cost of goods sold

 

 

2,123

 

267

 

81

 

10

 

45

 

12

 

 

2,538

Other expenses from operations

 

 

 

126

 

 

11

 

 

 

 

137

Selling, general and administrative

 

4

 

45

 

208

 

13

 

4

 

11

 

10

 

6

 

301

Interest expense

 

32

 

24

 

1

 

1

 

 

 

 

76

 

134

 

36

 

2,192

 

602

 

95

 

25

 

56

 

22

 

82

 

3,110

Income (loss) before income tax benefit (expense)

 

895

 

171

 

(37)

 

7

 

3

 

(1)

 

(5)

 

(50)

 

983

Income tax (expense) benefit

 

 

(30)

 

9

 

(1)

 

 

 

 

(76)

 

(98)

Net income (loss)

 

895

 

141

 

(28)

 

6

 

3

 

(1)

 

(5)

 

(126)

 

885

Less: net income attributable to non-controlling interests

 

481

 

80

 

 

1

 

 

 

 

 

562

Net income (loss) attributable to Icahn Enterprises

$

414

$

61

$

(28)

$

5

$

3

$

(1)

$

(5)

$

(126)

$

323

Supplemental information:

 

Capital expenditures

$

$

26

$

21

$

4

$

4

$

$

$

$

55

Depreciation and amortization

$

$

83

$

20

$

7

$

3

$

2

$

7

$

$

122

Disaggregation of Revenue

In addition to the condensed statements of operations by reporting segment above, we provide additional disaggregated revenue information for our Energy and Automotive segments below.

Energy

Three Months Ended March 31, 

    

2023

    

2022

Petroleum products

$

2,060

$

2,150

Nitrogen fertilizer products

 

226

 

223

$

2,286

$

2,373

Automotive

Three Months Ended March 31, 

    

2023

    

2022

Automotive services

$

369

$

353

Aftermarket parts sales

 

72

 

201

$

441

$

554

Condensed Balance Sheets

March 31, 2023

Investment

Energy

Automotive

Food
Packaging

Real
Estate

Home
Fashion

Pharma

Holding
Company

Consolidated

(in millions)

ASSETS

Cash and cash equivalents

$

22

$

601

$

34

$

13

$

41

$

6

$

23

$

1,868

$

2,608

Cash held at consolidated affiliated partnerships and restricted cash

 

2,384

 

7

 

9

 

 

7

 

3

 

 

71

 

2,481

Investments

 

6,520

 

103

 

 

 

14

 

 

 

 

6,637

Accounts receivable, net

 

 

330

 

53

 

86

 

12

 

24

 

22

 

 

527

Inventories, net

 

 

609

 

256

 

112

 

 

93

 

27

 

 

1,097

Related party notes receivable, net

207

207

Property, plant and equipment, net

 

 

2,647

 

797

 

139

 

343

 

55

 

 

5

 

3,986

Goodwill and intangible assets, net

 

 

195

 

348

 

24

 

 

19

 

219

 

 

805

Other assets

 

6,716

 

316

 

472

 

104

 

103

 

16

 

6

 

188

 

7,921

Total assets

$

15,642

$

4,808

$

1,969

$

478

$

520

$

216

$

297

$

2,339

$

26,269

LIABILITIES AND EQUITY

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

Accounts payable, accrued expenses and other liabilities

$

1,293

$

1,771

$

838

$

139

$

58

$

46

$

60

$

823

$

5,028

Securities sold, not yet purchased, at fair value

 

5,654

 

 

 

 

 

 

 

 

5,654

Debt

 

 

1,590

 

18

 

164

 

1

 

9

 

 

5,309

 

7,091

Total liabilities

 

6,947

 

3,361

 

856

 

303

 

59

 

55

 

60

 

6,132

 

17,773

Equity attributable to Icahn Enterprises

 

4,013

 

744

 

1,113

 

159

 

457

 

161

 

237

 

(3,793)

 

3,091

Equity attributable to non-controlling interests

 

4,682

 

703

 

 

16

 

4

 

 

 

 

5,405

Total equity

 

8,695

 

1,447

 

1,113

 

175

 

461

 

161

 

237

 

(3,793)

 

8,496

Total liabilities and equity

$

15,642

$

4,808

$

1,969

$

478

$

520

$

216

$

297

$

2,339

$

26,269

December 31, 2022

Investment

Energy

Automotive

Food
Packaging

Real
Estate

Home
Fashion

Pharma

Holding
Company

Consolidated

(in millions)

ASSETS

Cash and cash equivalents

$

19

$

510

$

32

$

9

$

26

$

5

$

16

$

1,720

$

2,337

Cash held at consolidated affiliated partnerships and restricted cash

 

2,455

 

7

 

10

 

 

8

 

3

 

 

66

 

2,549

Investments

 

6,719

 

76

 

 

 

14

 

 

 

 

6,809

Accounts receivable, net

 

 

358

 

99

 

87

 

12

 

24

 

26

 

 

606

Inventories, net

 

 

624

 

686

 

103

 

 

90

 

28

 

 

1,531

Property, plant and equipment, net

 

 

2,664

 

826

 

142

 

345

 

56

 

 

5

 

4,038

Goodwill and intangible assets, net

 

 

200

 

352

 

24

 

 

19

 

226

 

 

821

Other assets

 

8,041

 

296

 

527

 

110

 

102

 

16

 

6

 

125

 

9,223

Total assets

$

17,234

$

4,735

$

2,532

$

475

$

507

$

213

$

302

$

1,916

$

27,914

LIABILITIES AND EQUITY

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

Accounts payable, accrued expenses and other liabilities

$

1,589

$

1,823

$

981

$

149

$

47

$

45

$

61

$

70

$

4,765

Securities sold, not yet purchased, at fair value

 

6,495

 

 

 

 

 

 

 

 

6,495

Debt

 

 

1,591

 

21

 

162

 

1

 

12

 

 

5,309

 

7,096

Total liabilities

 

8,084

 

3,414

 

1,002

 

311

 

48

 

57

 

61

 

5,379

 

18,356

Equity attributable to Icahn Enterprises

 

4,184

 

648

 

1,530

 

149

 

455

 

156

 

241

 

(3,463)

 

3,900

Equity attributable to non-controlling interests

 

4,966

 

673

 

 

15

 

4

 

 

 

 

5,658

Total equity

 

9,150

 

1,321

 

1,530

 

164

 

459

 

156

 

241

 

(3,463)

 

9,558

Total liabilities and equity

$

17,234

$

4,735

$

2,532

$

475

$

507

$

213

$

302

$

1,916

$

27,914